CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 9 enrolled
Drug / intervention
kenalog +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04216017
NCT04216017Phase 2Completed
CompareCT.gov

A Randomized Controlled Pilot Study Evaluating the Efficacy of Early Glenohumeral Cortisone Injection in Patients With Shoulder Stiffness Following Proximal Humerus Fractures

University of Washington·interventional·Posted Jan 2, 2020·Updated Sep 26, 2023

In Brief

A Phase 2 clinical trial evaluating kenalog and Lidocaine for Humeral Fractures. Completed, enrolled 9 participants across 1 site.

Detailed Summary

The objective of this project is to determine if giving a cortisone injection to patients with proximal humerus fractures who have stiff shoulders recover their range of motion.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHumeral Fractures
CountriesUnited States
CollaboratorsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Timeline

Phase 2CompletedFinished
2020202120222023202420252026
First PostedJan 2, 2020
Enrollment StartJan 1, 2020
Primary CompletionApr 1, 2022
Study CompletionMay 1, 2022
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 6.5 years ago

Interventions

kenalogdrug

Cortisone injection into shoulder

Lidocainedrug

Lidocaine injection into shoulder